Home > Clinical Trial Transparency and Data Sharing > Chiesi Clinical Trial Data Request Portal

Autorizzo al trattamento dei miei dati personali
ai sensi del D.L. 30 giugno 2003 n. 196
Edit email address
Invalid email
Your request has been sent successfully
Authorize the processing of personal data
Enter the reserved area of the Portal
Enter required data
Invalid email
User not found
Reset password


You receive an email with new data for login access
Enter required data
User not found
Invalid email

Chiesi Clinical Trial Data Request Portal

Sharing Clinical Trial Data with Qualified Researchers

Chiesi commits to sharing with qualified scientific and medical Researchers, conducting legitimate research, Patient-level Data, Study-level Data, the Clinical Protocol and the full CSR of Chiesi Farmaceutici S.p.A.-sponsored interventional clinical trials in patients for medicines and indications approved by EMA and/or FDA after 1st January 2015.

Chiesi provides access to clinical trial information consistently with the principle of safeguarding commercially confidential information and patient privacy. Any shared Patient-level Data is anonymized to protect personally identifiable information.

Fundamental conditions for providing the requested clinical trial data are that qualified Researchers agree to sign a Data Sharing Agreement, to use the data only for non-commercial purposes and to seek publication of their research results.

Nevertheless, the access to clinical trial data is not be granted if any of the following apply:

  • There is a reasonable likelihood that individual patients could be re-identified: for example, clinical trials of rare diseases, single-centre clinical trials, or clinical trials with a very small number of subjects (< 50 subjects);
  • The external research has the purpose of re-evaluating safety and efficacy issues already addressed in the product labelling;
  • There are substantial practical and/or technical constraints to provide data access;
  • There are contractual or legal or patients’ informed consent provisions that prohibit the transfer of clinical trial data to third parties;
  • There is a potential conflict of interest or an actual or potential competitive risk;
  • Lack of necessary documentation related to the request.
Clinical Trial Data Request Process